The Hidden Patent War Shaping the Future of Digital Manufacturing

LOS ANGELES, CA – September 29, 2026 — When we think about the infrastructure that sustains modern society, we rarely picture the molecular bonds of photopolymer resins. Yet, as global supply chains continue to face unprecedented volatility, the ability to manufacture critical components locally, reliably, and at scale has become a cornerstone of economic resilience. This shift from centralized mass production to agile digital manufacturing is not just a technological evolution; it is a systemic transformation. And like all systemic shifts, it is being fiercely contested behind closed doors.

On Tuesday, that contest spilled into the public record. Carbon, a Silicon Valley-based leader in 3D printing technology, announced a decisive victory at the European Patent Office (EPO). The EPO’s Board of Appeal rejected a competitor’s challenge to one of Carbon’s foundational patents, upholding the broadest claims of its dual-cure chemistry. While this may read as a dry intellectual property dispute, it is in fact a defining moment for the future of the digital assembly line—dictating who gets to build the next generation of automotive parts, medical devices, and consumer goods across Europe.

The Mechanics of a Manufacturing Revolution

To understand why a single patent in Munich matters to a factory floor in Stuttgart or a dental lab in London, we must look at the historical bottleneck of 3D printing. For decades, additive manufacturing was trapped in the prototyping phase. Traditional light-based resin printing produced objects that were visually precise but structurally fragile. Parts cured purely by ultraviolet light were notorious for degrading, warping, or becoming brittle over time. They were perfect for showing a client a design, but useless for a car's engine bay or a patient's mouth.

Carbon’s breakthrough, protected by European Patent No. 3158400, fundamentally altered this equation by decoupling shape-setting from final material properties. The company's proprietary Digital Light Synthesis technology relies on a dual-cure process. First, ultraviolet light sculpts the liquid resin into a semi-rigid green state, acting essentially as a geometric scaffold. Second, the part is subjected to a thermal baking process in a convection oven. This heat activates dormant chemical groups within the resin, such as blocked polyurethanes or latent epoxies, forging a secondary cross-linked network.

The result is a paradigm shift. The final objects possess the isotropic tensile strength, impact resistance, and thermal stability of traditional injection-molded plastics. This is the chemistry that enables Adidas to print millions of elastomeric midsoles, Ford to manufacture durable electric vehicle brackets, and medical labs to produce custom pediatric orthotics. By patenting the overarching method of using dual-cure polymerizable liquids, Carbon did not just patent a chemical recipe; the company patented the bridge between 3D printing and serial mass production.

The Phantom Opponent and the High-Stakes Legal Chessboard

The sheer commercial value of this bridge explains the intense legal warfare surrounding it. The challenge at the EPO was formally brought by Oxon IP B.V., an intellectual property boutique based in Amsterdam. However, under EPO rules, this is a permitted strawman opposition—a mechanism allowing a specialized firm to file a challenge on behalf of an undisclosed industrial competitor.

This anonymous rival sought to invalidate Carbon’s patent on grounds of novelty and inventive step, hoping to clear the way for competing hardware and material ecosystems in Europe. Initially, they found partial success; an earlier Opposition Division ruling maintained the broadest claim but struck down several crucial dependent claims.

Tuesday’s Board of Appeal decision not only dismissed the competitor's appeal but granted Carbon’s cross-appeal, reinstating those vital dependent claims. These restored claims specify particular resin compositions, temperature ranges, and baking regimens, effectively creating a labyrinth of fallback defenses that make it exceedingly difficult for competitors to design around the patent.

Carbon’s aggressive defense of its intellectual property is underscored by its formidable legal roster. In Europe, the company was represented by Mairi Rudkin and Donald McNab of Marks & Clerk. Globally, Carbon has enlisted Myers Bigel for patent prosecution and Winston Taylor for litigation, notably deploying Kathi Vidal—a former Director of the United States Patent and Trademark Office—alongside Dustin Edwards. This legal fortress signals a clear readiness to assert its portfolio before the newly established Unified Patent Court and federal courts in the United States.

Locking Down the Digital Assembly Line

The ripple effects of this ruling will be felt immediately across the additive manufacturing ecosystem. The industry has seen a surge of competitors attempting to capitalize on the shift toward serial production. Hardware manufacturers like Stratasys, which acquired Origin specifically for its Programmable Photopolymerization technology, and 3D Systems with its Figure 4 platform, rely heavily on material ecosystems that require secondary thermal curing to achieve engineering-grade specifications. Furthermore, specialty chemical giants such as Henkel and BASF formulate open-market photopolymers that rely on similar post-processing bakes.

With the patent now firmly upheld, these competitors face substantial freedom-to-operate barriers across all EPC member states. If a rival's validated post-processing manual instructs a European customer to thermally bake a printed photopolymer to achieve its final properties, they may now be stepping directly into the crosshairs of Carbon’s patent enforcement.

"This decision confirms the strength and breadth of the innovation that is foundational to Carbon's platform," stated Philip DeSimone, CEO of Carbon, following the ruling. "Dual-cure chemistry enables the production of high-performance end-use products that previously were difficult or impractical to produce with other 3D printing technologies. We will continue to invest in and protect our innovations as we advance digital manufacturing."

For competitors, the paths forward are rapidly narrowing. They must either seek licensing agreements, restrict their European offerings to lower-performance single-cure resins, or invest heavily in alternative chemistries that bypass Carbon’s heavily fortified patent architecture.

Securing the Supply Chain of Tomorrow

Beyond the corporate rivalry, this legal validation matters profoundly for the broader economy and community well-being. We are living in an era where supply chain predictability is a strategic imperative. The enterprise partners that rely on Carbon’s technology—from Automobili Lamborghini to sprawling networks of dental laboratories—require long-term stability. When a hospital relies on a 3D-printed surgical guide, or a commuter depends on the structural integrity of an electric vehicle component, the underlying chemistry is no longer just a corporate asset; it is a matter of public trust.

In the automotive sector, changing a resin formulation or manufacturing process can trigger a cascade of re-certifications and safety testing. In the medical field, altering a material used for surgical guides or clear aligners necessitates navigating complex regulatory hurdles like CE marks or FDA approvals. Had Carbon’s patent been invalidated, the resulting influx of cheaper, potentially less reliable clone materials could have disrupted these highly regulated supply chains, jeopardizing both enterprise investments and consumer safety.

Instead, the EPO’s decision provides certainty. Enterprise procurement officers and plant managers can continue to integrate digital manufacturing into their operations without the looming threat of sudden vendor disruption or patent infringement actions. They are assured that the technological foundation upon which they are building their next-generation products remains legally sound and commercially protected.

Ultimately, the story of Carbon’s dual-cure patent is a story about the systems we trust to build our world. As society increasingly demands localized, sustainable, and customized production, the intellectual property that governs these processes becomes as critical as the physical infrastructure itself. By securing its foundational technology in Europe, Carbon has not only protected its own market share but has laid a stable, predictable paving stone on the path toward a more resilient digital economy.